首页> 外国专利> METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH DIURETIC AND URICOSURIC ACTION, AND METHOD FOR PREPARING FOR USE THEREOF 5- (1-OXO-METHYL-METHYL-5-METHYL) METHYL-METHYL-METHYL-METHYL-METHYL

METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH DIURETIC AND URICOSURIC ACTION, AND METHOD FOR PREPARING FOR USE THEREOF 5- (1-OXO-METHYL-METHYL-5-METHYL) METHYL-METHYL-METHYL-METHYL-METHYL

机译:具有利尿和糖尿作用的药物制剂的制备方法及其使用方法5-(1-氧代-甲基-甲基-甲基-5-甲基)甲基-甲基-甲基-甲基-甲基

摘要

1474460 Indanones MERCK & CO Inc 7 Oct 1974 [11 Oct 1973 30 July 1974] 26849/76 Divided out of 1474459 Heading C2C The invention comprises compounds of formula wherein R‹ is (a) Ph optionally substituted by NO 2 , OH, C 1-5 alkyl or alkoxy, cycloalkyl, halogen, NH 2 , CN, SO 2 , NH 2 , SO 2 Me or SO 2 Cl, or (b) thienyl optionally substituted by C 1-5 alkyl and/or halogen; R* is H, C 1-5 alkyl or aralkyl; A is O or S; R is (up to C 5 ) alkyl or alkenyl, Ph-C 1-3 alkyl, Ph-C 3-5 alkenyl, aryl (possibly substituted), cycloalkyl or cycloalkyl-C 1-5 alkyl, and RSP1/SP is H, C 1-5 alkyl or aryl, or R-RSP1/SP is a C 1-4 bivalent hydrocarbon chain; XSP1/SP is H, Z or Me and XSP2/SP is Z, Me or CZ 3 (where Z = halogen), or XSP1/SP-XSP2/SP is a C 3-4 bivalent hydrocarbon chain. In examples, these compounds are prepared by (i) introducing the substituent R‹ or R, (ii) converting the compound where R*A is MeO to the corresponding phenol, or (iii) introducing a CN or NO 2 group into the Ph ring represented by R‹. Details are given for the preparation of 2,2SP1/SP-dithienyl iodonium chloride and its substituted analogues. It is stated that certain compounds of the invention have diuretic, saluretic and uricosuic activity.
机译:1474460 Indanones MERCK&CO Inc 1974年10月7日[1973年10月11日1974年7月30日]除以1474459标题C2C划分本发明包括下式的化合物,其中R ‹是(a)任选被NO 2,OH,C 1取代的Ph -5烷基或烷氧基,环烷基,卤素,NH 2,CN,SO 2,NH 2,SO 2 Me或SO 2 Cl,或(b)任选被C 1-5烷基和/或卤素取代的噻吩基; R *是H,C 1-5烷基或芳烷基; A是O或S; R是(至多C 5)烷基或烯基,Ph-C 1-3烷基,Ph-C 3-5烯基,芳基(可能被取代),环烷基或环烷基-C 1-5烷基和R SP 1 是H,C 1-5烷基或芳基,或RR 1 是C 1-4二价烃链; X 1 是H,Z或Me,X 2 是Z,Me或CZ 3(其中Z =卤素)或X 1 - X 2 是C 3-4二价烃链。在实施例中,这些化合物是通过(i)引入取代基R ‹或R,(ii)将其中R * A为MeO的化合物转化为相应的苯酚,或(iii)将CN或NO 2基团引入Ph中制备的。 R ‹代表的环。给出了制备2,2 1 -二噻吩基碘鎓氯化物及其取代类似物的详细信息。据指出,本发明的某些化合物具有利尿,利尿和排尿活性。

著录项

  • 公开/公告号NL9100396A

    专利类型

  • 公开/公告日1991-06-03

    原文格式PDF

  • 申请/专利号NL19910000396

  • 申请日1991-03-05

  • 分类号C07C69/708;A61K31/12;A61K31/165;A61K31/19;A61K31/192;A61K31/195;A61K31/22;A61K31/38;A61K31/381;A61K31/495;A61K31/585;A61P7/10;C07C13/465;C07C45/46;C07C45/63;C07C45/65;C07C45/67;C07C45/68;C07C45/71;C07C49/613;C07C49/747;C07C49/755;C07C49/84;C07C51/00;C07C51/487;C07C59/125;C07C59/66;C07C59/68;C07C59/70;C07C59/86;C07C59/88;C07C59/90;C07C63/337;C07C67/00;C07C69/712;C07C201/00;C07C205/45;C07C225/22;C07C231/00;C07C231/02;C07C235/20;C07C235/30;C07C253/00;C07C255/13;C07C255/56;C07C301/00;C07C303/40;C07C311/16;C07C313/00;C07C315/04;C07C317/24;C07C319/14;C07C323/52;C07C333/18;C07D241/26;C07D257/04;C07D331/04;C07D333/04;C07D333/06;C07D333/18;C07D333/22;C07D333/26;C07D409/12;C07D475/08;

  • 国家 NL

  • 入库时间 2022-08-22 05:58:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号